购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-97(compound 4)是一种高效的 hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) 抑制剂,其IC50值 ≤0.1 µM。HSD17B13-IN-97 具有用于研究非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪性肝炎 (NASH) 以及药物性肝损伤 (DILI) 的潜力。
HSD17B13-IN-97(compound 4)是一种高效的 hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) 抑制剂,其IC50值 ≤0.1 µM。HSD17B13-IN-97 具有用于研究非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪性肝炎 (NASH) 以及药物性肝损伤 (DILI) 的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-97 (compound 4) is an effective inhibitor of hydroxysteroid 17ß-dehydrogenase 13 (HSD17B13), demonstrating an IC 50 value of ≤0.1 µM. This compound shows promise for studying Nonalcoholic fatty liver diseases (NAFLDs), nonalcoholic steatohepatitis (NASH), or drug-induced liver injury (DILI) [1]. |
分子量 | 458.37 |
分子式 | C22H14F4N4O3 |
CAS No. | 2849338-44-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容